Whole slide

I have heard this talked about for some time among the vendors, including Aperio and their CEO presented a couple of slides on this at the recent Pathology Visions meeting.  Came across this press release this morning. This service will...

Aperio has recently received FDA clearance for interpretation of progesterone receptor to its already approved HER2 clearance for digital reads as well as image analysis applications for ER and PR. Excellent news for signing out breast cancers...

In another sign of the pharma market for digital imaging, I came across this press release: "AgilityBio, a division of BioImagene Inc, and Advinus Therapeutics, a TATA enterprise, announced a partnership that will enable providing imaging...

I recently came across this press release which starts by saying "Aperio Technologies, Inc., (Aperio), has teamed with PDS Pathology Data Systems, Ltd. (PDS), an industry leader in providing preclinical toxicology, pathology,...

Researchers in Columbus, Ohio, and Los Angeles are collaborating on a groundbreaking effort that, when fully implemented, will allow health care experts around the world to have comprehensive information about a patient's tumor at their...

Earlier this week I had the good fortune of having the opportunity to speak at Pathology Visions in San Diego.  This annual meeting strives to bring together attendees from around the world to share best practices and learn about exciting...